All In MedTech

Device Trial Radar · NCT06483945

Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)

Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry

Last checked: Nov 19, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

5,000

Planned (sponsor's estimate)

Start

Feb 28, 2024

Primary completion

Mar 31, 2028

Study completion Jun 30, 2028

Sponsor

Lead sponsor
DexCom, Inc.Public (DXCM)
Sponsor type
Industry
First posted
Jul 3, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 2 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

"To evaluate the use of the Dexcom CGM System when used according to approved commercial labeling during standard clinical use and its impact on intended users in a real-world setting"

Conditions

  • Diabetes

Interventions

  • Dexcom CGM G6/G6 Pro/G7Device

    Dexcom CGM G6/G6 Pro/G7 device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Patient Reported Outcomes (PROs)Time frame: 4 years

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Institute of Endocrinology Diabetes, Health & Hormones

    Stockbridge, Georgia

  • Palm Research Center

    Las Vegas, Nevada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.